Product Information
GRALISE ER 750 MG TABLET is a brand product labeled by Almatica Pharma LLC, priced at $15.1857 per EA under NDC 52427085060. Its NADAC has been published 93 times since Sep 18, 2024.
The High Outlier badge above means this manufacturer's average price in the gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
750 mg/1
Manufacturer
Almatica Pharma LLCNDC
52427085060
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
9/17/2025
Active Ingredients
GABAPENTINApproval Type
New Drug (NDA)
FDA Application
NDA022544On Market Since
12/31/2023
Pharmacological Classes
Price Statistics
The NADAC for GRALISE ER 750 MG TABLET has been published 93 times since Sep 18, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.1857 per EA |
|---|---|
| All-time high | $15.2980 (Oct 16, 2024) |
| All-time low | $15.1857 (Sep 17, 2025) |
| 52-week high | $15.2570 |
| 52-week low | $15.1857 |
| Median price | $15.2060 |
| Average price | $15.2314 |
| Largest weekly change | -0.3% (Jul 23, 2025) |
| Weeks tracked | 93 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the gabapentin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of GRALISE ER 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GRALISE ER 750 MG TABLET, manufactured by Almatica Pharma LLC, is $15.1857 per EA (NDC 52427085060), effective Jun 24, 2026.
How has the price of GRALISE ER 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for GRALISE ER 750 MG TABLET has held within roughly two percent of its current level. It has been tracked across 93 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for GRALISE ER 750 MG TABLET?
Since Sep 18, 2024, the NADAC for GRALISE ER 750 MG TABLET has ranged from a low of $15.1857 (Sep 17, 2025) to a high of $15.2980 (Oct 16, 2024), with a median of $15.2060 per EA.
Are there cheaper alternatives to GRALISE ER 750 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of GRALISE ER 750 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures GRALISE ER 750 MG TABLET?
GRALISE ER 750 MG TABLET (NDC 52427085060) is labeled by Almatica Pharma LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification